NeuroOne Medical Technologies Corporation
NMTC
$0.75
$0.011.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2,008.30% | 105.39% | 0.68% | 234.92% | -63.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2,008.30% | 105.39% | 0.68% | 234.92% | -63.29% |
| Cost of Revenue | 87.20% | 12.95% | -36.97% | 14.80% | -46.52% |
| Gross Profit | 450.67% | 70.67% | 128.11% | 162.01% | 38.66% |
| SG&A Expenses | -3.39% | -13.93% | -3.12% | -5.98% | 16.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.24% | -1.02% | -4.62% | -64.22% | -20.93% |
| Operating Income | 51.32% | 32.47% | 7.14% | 150.47% | 11.00% |
| Income Before Tax | 51.67% | 45.77% | 20.47% | 153.37% | -6.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 51.67% | 45.77% | 20.47% | 153.37% | -6.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.67% | 45.77% | 20.47% | 153.37% | -6.87% |
| EBIT | 51.32% | 32.47% | 7.14% | 150.47% | 11.00% |
| EBITDA | 52.53% | 33.35% | 7.46% | 153.31% | 11.27% |
| EPS Basic | 71.26% | 69.47% | 33.76% | 141.54% | 20.17% |
| Normalized Basic EPS | 90.74% | 62.97% | 22.35% | 141.56% | 21.83% |
| EPS Diluted | 71.26% | 69.47% | 33.76% | 141.36% | 20.17% |
| Normalized Diluted EPS | 90.74% | 62.97% | 22.35% | 141.45% | 21.83% |
| Average Basic Shares Outstanding | 67.93% | 77.70% | 20.07% | 28.51% | 33.90% |
| Average Diluted Shares Outstanding | 67.93% | 77.70% | 20.07% | 28.69% | 33.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |